Clinical Research Directory
Browse clinical research sites, groups, and studies.
3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
Sponsor: Shengjing Hospital
Summary
How to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis or advanced chronic liver disease. We plan to investigate the ability of three demensional-magnetic resonance elastography (3D-MRE) to establish a risk stratification system and perform tailored management for portal hypertension in cirrhosis or advanced chronic liver disease.
Official title: Three-dimensional MR Elastography for Assessing Cirrhosis and Portal Hypertension (CHESS2206): A Prospective Multicenter Study
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2022-08-16
Completion Date
2026-12-01
Last Updated
2026-02-09
Healthy Volunteers
No
Interventions
3D-MRE
All imaging studies were performed by using a 3.0-T MRI system ( GE Healthcare) with a phasedarray body coil.
HVPG
HVPG measurements are performed by well-trained interventional radiologists in accordance with standard operating procedures.
Locations (1)
Shengjing Hospital
Shenyang, Liaoning, China